Our data showed infiltration of T (CD3+), CD8 T (CD8+) and B cells (CD20+) in more than 50% of the tumor samples and a lower infiltration of CD4 T cells (CD4+) and CL (TIA1+). This evidence concerns the gene CD4 and neoplasm.